elderly underactive bladder symptoms needed to be reported

Drug Tied to Dementia Risk Overprescribed to Seniors: Study

A drug linked to a raised risk of dementia is taken by millions of older Americans who have an overactive bladder, researchers say.  More than one-quarter of patients with the urinary problem had been prescribed the drug oxybutynin (Ditropan), an international team of investigators found.  Yet, “oxybutynin is a particularly poor drug for overactive bladder in elderly patients,” said study lead author Dr. Daniel Pucheril, a urologist at Henry Ford Hospital in Detroit.  Prior studies have linked the drug to thinking problems and increased risk of dementia in older people, possibly because of the way it affects brain chemicals, he said.  “It’s a great and effective drug for younger patients, but is a risky drug for older patients,” Pucheril said. It boosts dementia risk even when not taken indefinitely, he said.  Alternatives exist but they’re more expensive and may not be covered by insurance, at least initially, the study authors explained.  Read more.

Source: HealthDay News, March 30, 2017

surgeons perform pelvic organ prolapse surgery

How a Ring of Titanium Beads Can Help Fecal Incontinence

A new device made up of magnetic titanium beads may help certain patients who have problems controlling their bowels, a condition called fecal incontinence.  The Fenix® Continence Restoration System mimics the function of the anal sphincter. It is the newest treatment option available to certain patients who have fecal incontinence caused by childbirth complications, trauma, prior surgeries, anal sex or another cause of muscle and nerve damage.  Read more.

Source: Cleveland Clinic, March 9, 2017

Apple iPhone

New System Uses Remote Medical Monitoring, Mobile Games to Improve At-Home Pelvic Floor Muscle Training

Urinary incontinence is any involuntary urine leakage. It is a condition that can be more or less severe and it affects one in three women of all ages, which is more than 56 million people in Europe and more than 350 million people in the world. It is not a normal part of ageing and has a negative impact on the quality of life of the women who suffer from it. The main risk factors for urinary incontinence are pregnancy and childbirth, overweight and obesity, and high-impact sports. There are several treatments to improve or cure its symptoms, depending on the type of incontinence, and it can also be prevented by taking measures before it appears.  One approach that has proven effective in preventing and treating stress urinary incontinence is pelvic floor muscle training. It consists of a programme of contraction and relaxation exercises for the muscles that form the base of the pelvis. If the treatment is followed and performed correctly with the supervision of a therapist, the rate of cure/improvement may reach 70% .Read more.

Source: News-Medical.net, March 9, 2017

product approval introduction

FDA Approves First Treatment for Frequent Urination at Night Due to Overproduction of Urine

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night). Noctiva is the first FDA-approved treatment for this condition.  “Today’s approval provides adults who overproduce urine at night with the first FDA-approved therapeutic option to help reduce the number of times a night they wake up to urinate,” said Hylton V. Joffe, M.D., M.M.Sc., director of the Division of Bone, Reproductive, and Urologic Products in the FDA’s Center for Drug Evaluation and Research. “It is important to know that Noctiva is not approved for all causes of night-time urination, so patients should discuss their symptoms with their health care provider who can determine the underlying cause of the night-time urination and whether Noctiva is right for them.”  Read more.

Source: US FDA, March 3, 2017

business buildings

HARTMANN Group to Acquire P&G Incontinence Brand in Spain/Portugal

The HARTMANN GROUP, a leading international supplier of medical and hygiene products, announced today it plans to acquire Procter & Gamble’s Lindor — one of the most well-known adult incontinence brands in the Spain and Portugal professional channel. The transaction seeks to take place by end of second quarter of fiscal year 2017 and is subject to approval by local antitrust authorities.  As part of the agreement, HARTMANN is slated to obtain all P&G assets associated with the Lindor product portfolio (Lindor, Salvacamas, Lindor Care, Lindor Pants), Intellectual Property, contracts with employees, as well as a 25,000-square metre manufacturing facility in Montornés, Spain. Read more.

Source: Yahoo Finance, March 2, 2017

nurse and patient

Third Randomized Controlled Trial (RCT) of the Vesair™ Bladder Control System For the Treatment of Stress Urinary Incontinence Delivers Promising Results

Solace Therapeutics, Inc., today announced that data from a multicenter 221 patient randomized controlled trial has met study endpoints with statistical significance. Dr. Eric Rovner will be presenting a poster of the results from the SUCCESS Clinical Trial at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) meeting in Scottsdale, Arizona on Thursday, March, 2nd.  This is the Company’s third randomized controlled trial to evaluate the safety and efficacy of the Vesair Bladder Control System; a novel, office-based, reversible treatment designed to reduce or eliminate urine leakage in female patients with Stress Urinary Incontinence (SUI).  Read more.

Source: Business Wire, March 1, 2017

school girl education

NMC Urged to Tackle ‘Glaring Hole’ in Bowel and Bladder Education

A “glaring hole” in training that is failing to ensure nurses are taught bowel and bladder care is putting patients at risk, a group of MPs has warned. In a letter to the Nursing and Midwifery Council, the All Party Parliamentary Group for Continence Care urged the regulator to consider including such training in pre-registration education, as part of its current review of university standards.  The group of MPs said it was a concern that it was not a core competency for nurses, considering that fact that more than 14 million adults in the UK had bladder control problems and 6.5 million have bowel control issues, and 900,000 children and young people have bladder and bowel dysfunction. Read more.

Source: Nursing Times, March 1, 2017

women exercising

Pelvic Floor Symptoms May Lead To Exercise Avoidance in Menopausal Women

Physical activity improves health and may delay the onset of chronic diseases. For women in particular, the rate of some chronic diseases accelerates at middle age around the time of menopause; therefore it is important to identify the determinants of health-enhancing physical activity during midlife in this population. The main aim of this study was to characterize the level of physical activity and to examine the association between different female reproductive factors and objectively-measured physical activity in middle-aged women. The reproductive factors included cumulative reproductive history index, and perceived menopausal and pelvic floor dysfunction symptoms. Read more.

Source: MedicalResearch.com, Feburary 28, 2017

bladder retraining timed intervals

Hatch Medical to Broker Innovative Male Urinary Incontinence Device

Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has entered into an agreement with MUCOM, L.L.C. to broker the sale or license of its patented male urinary incontinence device MUI Comfort™. MUI Comfort™ is an integrated external collection system that meets the needs of a growing demographic that is coping with the consequences of stress, urge, and overflow incontinence. This innovative technology is differentiated from competing products by providing a complete solution that addresses both functional and psychological aspects associated with male urinary incontinence.  Read more.

Source: Yahoo Finance! February 16, 2017

stem cell tissue regeneration

USC Viterbi Researcher’s Work Seeks to Help Those Who Really Have to Go

Tissue regeneration gets the attention of Eun Ji Chung, a USC researcher who also studies a common and distressing problem: bladder control.  Chung, an assistant professor at the USC Viterbi School of Engineering, examines how tissue regeneration could help patients with urinary incontinence caused by the loss or weakened control of the muscle controlling the release of urine from the bladder. The problem affects millions, especially women and females who have given birth. She hopes to provide a solution by restoring urethral tissue form and function. The goal: to develop biocompatible and bioactive hydrogels that can release growth factors and stimulate muscle repair using adipocytes, or fat stem cells, for the urethra, she said. Read more.

Source: USC News, February 13, 2017